Catherine Jones

PI 3-kinase p110β: a new target for antithrombotic therapy

Shaun P. Jackson, Simone M. Schoenwaelder, Isaac Goncalves et al. · Nature Medicine · 2005 · 589 citations

Medicine, Molecular Medicine, Pharmacology +15

Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer

A. Bapsi Chakravarthy, Mark C. Kelley, Bernadette K. McLaren et al. · Clinical Cancer Research · 2006 · 73 citations

Medicine, Oncology, Radiation Oncology +17

Haemolytic-uraemic syndrome. A report of an outbreak.

M. M. McLean, Catherine Jones, Donald A. Sutherland · Archives of Disease in Childhood · 1966 · 56 citations · Full text

Medicine, Hematology, Infectious Diseases +13

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

Rei Kudo, Anton Safonov, Catherine Jones et al. · Cancer Cell · 2024 · 47 citations · Full text

Medicine, Cancer Biology, Oncology +14

Advantages of a selective β-isoform phosphoinositide 3-kinase antagonist, an anti-thrombotic agent devoid of other cardiovascular actions in the rat

Sharelle A. Sturgeon, Catherine Jones, James A. Angus et al. · European Journal of Pharmacology · 2008 · 42 citations

Medicine, Cardiology, Pharmacology +8